External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice.

Autor: Hamers PAH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., van Smeden M; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, 3511 DT Utrecht, The Netherlands., Smabers LP; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., Lunenberg RA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands., May AM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2022 Oct 18; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 18.

External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population.

Autor: Bond MJG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Hamers PAH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van Grevenstein WMU; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Smeden M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Punt CJA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 May; Vol. 61 (5), pp. 560-565. Date of Electronic Publication: 2022 Mar 07.

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.

Autor: Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Elferink MAG; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508GA, Utrecht, The Netherlands., Mol L; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Hamers PAH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medical Center, Postbus 210, 1500EE, Zaandam, The Netherlands., Creemers GJ; Department of Medical Oncology, Catharina Hospital, Postbus 1350, 5602ZA, Eindhoven, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Hospital, Dokter van Heesweg 2, 8025AB, Zwolle, The Netherlands., de Klerk GJ; Department of Medical Oncology, Spaarne Gasthuis, Spaarnepoort 1, 2134TM, Hoofddorp, The Netherlands., Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Postbus 9100, 3007AC, Rotterdam, The Netherlands., Haringhuizen AW; Department of Medical Oncology, Hospital Gelderse Vallei, Willy Brandtlaan 10, 6716RP, Ede, The Netherlands., Hoekstra R; Department of Medical Oncology, Ziekenhuisgroep Twente, Postbus 7600, 7600SZ, Almelo, The Netherlands., Hunting JCB; Department of Medical Oncology, St. Antonius Hospital, Postbus 2500, 3430EM, Nieuwegein, The Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Oosterpark 9, 1091AC, Amsterdam, The Netherlands., Mathijssen-van Stein D; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Vlietlandplein, 3118JH, Schiedam, The Netherlands., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Postbus 888, 8901BR, Leeuwarden, The Netherlands., Pruijt JFM; Department of Medical Oncology, Jeroen Bosch Hospital, Postbus 90153, 5200ME, 's-Hertogenbosch, The Netherlands., Quarles van Ufford-Mannesse P; Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545AA, den Haag, The Netherlands., Radema S; Department of Medical Oncology, Radboud University Medical Center, Postbus 9101, 6500HB, Nijmegen, the Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Postbus 1074, 1940EB, Beverwijk, The Netherlands., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Postbus 90052, 5600PD, Eindhoven, The Netherlands., Tanis BC; Department of Medical Oncology, Groene Hart Hospital, Bleulandweg 10, 2803HH, Gouda, The Netherlands., Ten Bokkel Huinink D; Department of Medical Oncology, Diakonessenhuis Utrecht, Postbus 80250, 3508TG, Utrecht, The Netherlands., Tjin-A-Ton MLR; Department of Medical Oncology, Hospital Rivierenland, President Kennedylaan 1, 4002WP, Tiel, The Netherlands., Tromp-van Driel CS; Department of Medical Oncology, Gelre Hospital, Postbus 9014, 7300DS, Apeldoorn, The Netherlands., Troost MM; Department of Medical Oncology, Bravis Hospital Bergen op Zoom, Postbus 999, 4700AZ, Roosendaal, The Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Heerlen, Postbus 5500, 6130MB, Sittard-Geleen, The Netherlands., van der Pas AJM; Department of Medical Oncology, LangeLand Hospital, Postbus 3015, 2700KJ, Zoetermeer, The Netherlands., van der Velden AMT; Department of Medical Oncology, Tergooi, Van Riebeeckweg 212, 1213XZ, Hilversum, The Netherlands., van Dijk MA; Department of Medical Oncology, ZorgSaam Hospital, Wielingenlaan 2, 4535PA, Terneuzen, The Netherlands., van Dodewaard-de Jong JM; Department of Medical Oncology, Meander Medical Center, Postbus 1502, 3800BM, Amersfoort, The Netherlands., van Druten EB; Department of Medical Oncology, Reinier de Graaf Gasthuis, Postbus 5011, 2600GA, Delft, The Netherlands., van Voorthuizen T; Department of Medical Oncology, Hospital Rijnstate, Wagnerlaan 55, 6815AD, Arnhem, The Netherlands., Jan Veldhuis G; Department of Medical Oncology, Antonius Hospital Sneek, Postbus 20000, 8600BA, Sneek, The Netherlands., Verheul HMW; Department of Medical Oncology, Amsterdam University Medical Center, VU Medical Center, P.O. Box 7057, 1007MB, Amsterdam, The Netherlands., Vestjens HJHMJ; Department of Medical Oncology, VieCuri Medical Center, Postbus 1926, 5900BX, Venlo, The Netherlands., Vincent J; Department of Medical Oncology, Elkerliek Hospital, Postbus 98, 5700AB, Helmond, The Netherlands., Kranenburg OW; Department of Surgical Oncology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands.; Utrecht Platform for Organoid Technology, University Medical Center Utrecht, Utrecht University, Postbus 98, 5700AB, Utrecht, The Netherlands., Punt CJA; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Postbus 22660, Amsterdam, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 19079, 3501DB, Utrecht, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584CG, Utrecht, The Netherlands. M.Koopman-6@umcutrecht.nl.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (2), pp. 399-406. Date of Electronic Publication: 2020 Oct 13.